Published

Neuralink to implant its brain chips in Canada

  • Neuralink has received approval to begin its first clinical trial in Canada, which signifies an expansion of its testing outside the United States.
  • The University Health Network in Toronto will host the Canadian trial named CAN-PRIME, assessing safety and functionality.
Insights by Ground AI
Does this summary seem wrong?
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Right
67% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)